TGen TCRS Clinical TrialsThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the latest items in this publication.

A multicenter, Open Label, Randomized phase 2 Study to Evaluate the Efficacy and Safety of NKTR-102 (Peg Irinotecan) Versus Irinotecan in Patients with Second Line, Irinotecan Naïve, KRAS mutant, Colorectal CancerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - June 16, 2009 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Phase I, multicenter, Open-label, Dose-Escalation, Safety, Pharmacodynamic, and Pharmacokinetic Study of PEGPH20 (PEGylated Recombinant Human Hyaluronidase) Given Intravenously to Patients with Advanced Solid TumorEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - June 16, 2009 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Phase 1 Dose Escalation Study of ARQ 621 in Adult Patients with Metastatic Solid TumorsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - April 1, 2009 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Phase 1/Randomized Phase 2 Study to Evaluate LY2603618 in Combination with Gemcitabine in Patients with Pancreatic CancerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - April 1, 2009 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Phase 1 Dose Escalation Study of TAK 901 in Subjects with Advanced Hematologic MalignanciesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - April 1, 2009 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Dose- Escalation Study to Evaluate the Safety, Tolerability, and Pharmacology of VTX-2337 When Administered to Adult Subjects With Solid Tumors or LymphomaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - April 1, 2009 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacology of VTX-2337 When Administered to Adult Subjects With Solid Tumors or LymphomaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - December 16, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Phase 1 Study of IPI-926 in patients with advanced and/or metastatic solid tumor malignanciesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - October 10, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Phase 1 Study of SCH 900105 Administered by IV Infusion in Advanced Solid Tumors or LymphomasEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - October 9, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Phase 1, Multicenter, Open-Label, Dose Escalation Trial of PDL192 in Subjects with Advanced Solid TumorsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - October 8, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Phase I, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of E6201 Administered Once Weekly for 3 Weeks (days 1, 8, and 15 of a 28-day Cycle) in Subjects with Advanced Solid TumorsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - October 7, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Phase I, Multi-center, Open-Label, Dose-Escalation, safety, Pharmacokinetic, and Pharmacodynamic Study of UNBS5162 Administered IV Weekly for Three Weeks and Repeated Every Four Weeks to Patients with Advanced Solid Tumors or LymphomaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - October 6, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Phase Ib Trial of PX-12 Administered as a 72-hr Infusion Every 21 Days in Patients with a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metastatic cancer that is Refractory to Standard TherapyEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - October 5, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

An open label phase 1 dose finding study of TRC102 in combination with pemetrexed in patients with advanced or metastatic solid cancer for whom curative therapy is unavailableEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - October 4, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Dose Escalation Study Evaluating MK-1775 in Both Monotherapy and in combination with either Gemcitabine, Cisplatin or Carboplatin in Adult Patients with Advanced Solid TumorsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - October 3, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Phase I Study of Liposome Entrapped Docetaxel (LE-DT) in Patients with Advanced Solid TumorsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - October 2, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Phase I Study of IPI-504 and Docetaxel in Patients with Advanced Solid TumorsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - October 1, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

Multicenter, Open-label, Phase 2 study of NKTR-102 in combination with Cetuximab for patients with Metastatic or Locally Advanced DiseaseEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - September 30, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Phase I Dose-Escalation Study of LY2495655, an Anti-Myostatin Monoclonal Antibody, in Patients with Advanced CancerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - September 29, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Multi-Center Phase 1, Dose-Escalation Trial to Determine the Safety and Pharmacokinetics/Pharmacodynamics of RDEA119, a MEK Inhibitor, in Advance Cancer PatientsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - September 28, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

An Open-Label, Phase I, Dose-Escalation Study of PI3 Kinase Inhibitor (GDC-0941) in Patients with Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or IntolerableEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - September 27, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Phase I-Multi-Center, Open Label, Dose Escalation, Safety, Pharmacodynamic and Pharmacokinetic Study of PRLX 93936 Administered Intravenously Daily for Five Days Followed by a 23 Day Rest Period in Patients With Advanced Solid TumorEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - September 26, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Phase I Trial of Oral PX-478 (a HIF-1a Inhibitor) in Patients with Advanced Solid Tumors or LymphomaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - September 25, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Phase I, Multi-Center, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics and Anti-Tumor Activity of TH-302 in Patients with Advances Solid TumorsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - September 24, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

Phase I Study of Terameprocol (EM-1421), A Survivin and Cyclin-Dependent-Kinase-1 (Cdc2) Inhibitor, in Patients with LeukemiaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - September 23, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Safety Study to Determine the Maximum Tolerated Dose, Pharmacokinetic, Pharmacodynamics of Oral MP-470, A Multitargeted Tyrosine Kinase Inhibitor, in Patients with Solid MalignanciesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - September 22, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Phase 1, Open-label, Dose-escalation Study of the Safety and Pharmacokinetics of SNX 5422 Mesylate in Subjects with Refractory Solid Tumor MalignanciesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - September 21, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous XMT-1001 in Patients With Advanced Solid TumorsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - September 20, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Phase Ib, Multi-center, Dose Escalation Trial Of Intravenous PR-104 Given In Combination With Docetaxel Or Gemcitabine In Subjects With Solid TumorsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - September 19, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Phase I Open Label, Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation Study in SF1126, a PI Kinase (PI3K) Inhibitor, Given Twice Weekly by IV Infusion to Patients With Advanced or Metastatic TumorsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - September 18, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

An Open-Label, Phase I Study of a Hedgehog Pathway Antagonist, GDC-0449, in Patients with Locally Advanced Or Metastatic Solid Tumors That are Refractory to Standard Therapy of for Whom No Standard Therapy ExistsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - September 17, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Phase I Dose-Escalation Study to Examine the Safety and Tolerability of IC83 Administered 1 Day After Pemetrexed 500mg/m2 Every 21 Days In Patients with CancerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - September 16, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A First in Man Phase I Study of EPC2407, a Microtubule Inhibitor Anti-Cancer Drug with Tumor Vascular Endothelial Disrupting Activity: Intravenous Administration Daily for Three Days in Patients with Advanced Solid Tumors and LymphomasEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - September 15, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Multi-center, Phase 1, Open-Label, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of NKT-10002 in Subjects With Refractory Solid TumorsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - September 14, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Randomized Phase II Open-Label Study of Two Different Dose Levels of PX.-12 in Patients with Advanced Carcinoma of the Pancreas Whose Tumors Have Progressed on Gemcitabine or on a Gemcitabine-Containing CombinationEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - September 13, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

Phase I Clinical and Pharmacokinetic Study of CBP501 and cisplatin every 3 weeks in patients with advanced refractory solid tumors - 06-01Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - September 12, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials

A Pilot Study Utilizing Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory CancersEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...
Source: TGen TCRS Clinical Trials - September 11, 2008 Category: Cancer & Oncology Tags: Clinical Trials Source Type: clinical trials